230 related articles for article (PubMed ID: 32948837)
1. An unanticipated tumor-suppressive role of the SUMO pathway in the intestine unveiled by Ubc9 haploinsufficiency.
López I; Chalatsi E; Ellenbroek SIJ; Andrieux A; Roux PF; Cerapio JP; Jouvion G; van Rheenen J; Seeler JS; Dejean A
Oncogene; 2020 Oct; 39(43):6692-6703. PubMed ID: 32948837
[TBL] [Abstract][Full Text] [Related]
2. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function.
He X; Lai Q; Chen C; Li N; Sun F; Huang W; Zhang S; Yu Q; Yang P; Xiong F; Chen Z; Gong Q; Ren B; Weng J; Eizirik DL; Zhou Z; Wang CY
Diabetologia; 2018 Apr; 61(4):881-895. PubMed ID: 29299635
[TBL] [Abstract][Full Text] [Related]
3. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
4. Spatiotemporal distribution of SUMOylation components during mouse brain development.
Hasegawa Y; Yoshida D; Nakamura Y; Sakakibara S
J Comp Neurol; 2014 Sep; 522(13):3020-36. PubMed ID: 24639124
[TBL] [Abstract][Full Text] [Related]
5. SUMOylation pathway alteration coupled with downregulation of SUMO E2 enzyme at mucosal epithelium modulates inflammation in inflammatory bowel disease.
Mustfa SA; Singh M; Suhail A; Mohapatra G; Verma S; Chakravorty D; Rana S; Rampal R; Dhar A; Saha S; Ahuja V; Srikanth CV
Open Biol; 2017 Jun; 7(6):. PubMed ID: 28659381
[TBL] [Abstract][Full Text] [Related]
6. Ubc9 negatively regulates BMP-mediated osteoblastic differentiation in cultured cells.
Yukita A; Hosoya A; Ito Y; Katagiri T; Asashima M; Nakamura H
Bone; 2012 May; 50(5):1092-9. PubMed ID: 22366399
[TBL] [Abstract][Full Text] [Related]
7. Sumoylation by Ubc9 regulates the stem cell compartment and structure and function of the intestinal epithelium in mice.
Demarque MD; Nacerddine K; Neyret-Kahn H; Andrieux A; Danenberg E; Jouvion G; Bomme P; Hamard G; Romagnolo B; Terris B; Cumano A; Barker N; Clevers H; Dejean A
Gastroenterology; 2011 Jan; 140(1):286-96. PubMed ID: 20951138
[TBL] [Abstract][Full Text] [Related]
8. The SUMO conjugating enzyme Ubc9 is required for inducing and maintaining stem cell pluripotency.
Tahmasebi S; Ghorbani M; Savage P; Gocevski G; Yang XJ
Stem Cells; 2014 Apr; 32(4):1012-20. PubMed ID: 24706591
[TBL] [Abstract][Full Text] [Related]
9. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
Niedenthal R
Methods Mol Biol; 2009; 497():63-79. PubMed ID: 19107411
[TBL] [Abstract][Full Text] [Related]
10. Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.
Subramaniam S; Mealer RG; Sixt KM; Barrow RK; Usiello A; Snyder SH
J Biol Chem; 2010 Jul; 285(27):20428-32. PubMed ID: 20424159
[TBL] [Abstract][Full Text] [Related]
11. DNA repair and global sumoylation are regulated by distinct Ubc9 noncovalent complexes.
Prudden J; Perry JJ; Nie M; Vashisht AA; Arvai AS; Hitomi C; Guenther G; Wohlschlegel JA; Tainer JA; Boddy MN
Mol Cell Biol; 2011 Jun; 31(11):2299-310. PubMed ID: 21444718
[TBL] [Abstract][Full Text] [Related]
12. Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion.
Kim ET; Kim KK; Matunis MJ; Ahn JH
Biochem Biophys Res Commun; 2009 Oct; 388(1):41-5. PubMed ID: 19635459
[TBL] [Abstract][Full Text] [Related]
13. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae.
Klug H; Xaver M; Chaugule VK; Koidl S; Mittler G; Klein F; Pichler A
Mol Cell; 2013 Jun; 50(5):625-36. PubMed ID: 23644018
[TBL] [Abstract][Full Text] [Related]
14. Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model.
McMillan LE; Brown JT; Henley JM; Cimarosti H
Neurosci Lett; 2011 Sep; 502(3):201-8. PubMed ID: 21843595
[TBL] [Abstract][Full Text] [Related]
15. Elevated global SUMOylation in Ubc9 transgenic mice protects their brains against focal cerebral ischemic damage.
Lee YJ; Mou Y; Maric D; Klimanis D; Auh S; Hallenbeck JM
PLoS One; 2011; 6(10):e25852. PubMed ID: 22016779
[TBL] [Abstract][Full Text] [Related]
16. UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts.
Gupta MK; McLendon PM; Gulick J; James J; Khalili K; Robbins J
Circ Res; 2016 Jun; 118(12):1894-905. PubMed ID: 27142163
[TBL] [Abstract][Full Text] [Related]
17. Sumoylation of human argonaute 2 at lysine-402 regulates its stability.
Sahin U; Lapaquette P; Andrieux A; Faure G; Dejean A
PLoS One; 2014; 9(7):e102957. PubMed ID: 25036361
[TBL] [Abstract][Full Text] [Related]
18. Effect of endosulfan and bisphenol A on the expression of SUMO and UBC9.
Yarahalli Jayaram V; Baggavalli S; Reddy D; Sistla S; Malempati R
Drug Chem Toxicol; 2020 Nov; 43(6):637-644. PubMed ID: 30426790
[TBL] [Abstract][Full Text] [Related]
19. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
Goffinont S; Coste F; Prieu-Serandon P; Mance L; Gaudon V; Garnier N; Castaing B; Suskiewicz MJ
J Biol Chem; 2023 Jul; 299(7):104870. PubMed ID: 37247759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
